Berenberg Bank analyst Luisa Hector maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.00.

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...

Relation Therapeutics and GSK signed two contracts to discover and develop new therapeutic targets to treat osteoarthritis and fibrotic disease. The U.K. biotech will receive a total upfront ...

GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for fibrotic diseases and osteoarthritis. The two-stranded collaboration will ...

Relation Therapeutics is teaming with GSK on two multi-program strategic collaborations. The partnership announced on Tuesday morning will prioritize the development of novel disease targets for ...

London, UK, December 10, 2024 – Relation, an industry leader in deploying computation and experimentation to drug discovery, today announced two multi-program strategic collaborations with GSK. The ...